Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences
Kronox Lab Sciences Ltd 路 Change in Management 路 30 Sept 2026, 12:05 am
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences On 29th Sep'26, Indo Borax & Chemicals Limited completed the acquisition of 2,38,44,000 equity shares (64.26% stake) in Kronox Lab Sciences Limited from selling promoters under the SPA dated 20th Aug'26. The sellers now retain 9.95% voting equity and cease to be promoters. Concurrently, Kronox overhauled its leadership: Suresh Kalra was appointed MD & CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO, alongside three new independent directors, following resignations of previous promoters and key management personnel.
Original exchange filing (PDF)
More announcements from Kronox Lab Sciences Ltd
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... 路 11 Nov 2026
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 10, 2026 for Indo Borax .... 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd 路 06 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 05, 2026 for Indo Borax & Chemicals Ltd 路 06 Nov 2026
- IIFL Capital Services Ltd (formerly known as IIFL Securities Ltd) ("Manager to the Open Offer") has submitted to BSE a copy of Offer Opening Public Announcement in accordance with Regulation .... 路 05 Nov 2026
- Results -Financail Resutls for the Quarter and Half Year ended September 30, 2026 路 05 Nov 2026
- Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Outcome of Board Meeting held on Thursday, November 05, 2026 inter to consider and approve unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026 路 05 Nov 2026
